RIGI and cancer: On the other hand, we found that the residual IFN production triggered by poly(dA:dT) was instead regulated by the RIG-I pathway, and that stimulation with the 5’ppp-RNA RIG-I agonist M8 led to transcriptional activation and secretion of type I and III IFNs in HPV+ cancer cells [21, 22].